Parturient Paresis (Milk Fever, Clinical Hypocalcemia, Puerperal Hypocalcemia)

Parturient paresis, commonly known as milk fever or clinical hypocalcemia, is an acute, afebrile, flaccid paralysis of mature dairy cows occurring most frequently within 72 hours after parturition, but can also occur in beef cattle and occasionally in non-puerperal situations. It is caused by a sudden and severe drop in blood calcium concentration, typically below 5.5 mg/dL (ionized calcium < 1.0 mmol/L), due to the abrupt onset of lactation and the failure of homeostatic mechanisms to mobilize calcium from bone and increase intestinal absorption rapidly enough to meet the massive calcium demand of colostrum and milk synthesis. The disease is characterized by progressive neurological and muscular dysfunction, leading to sternal recumbency, lateral recumbency, and coma if untreated. It is a medical emergency that requires prompt intravenous calcium therapy. The condition is economically significant due to mortality, treatment costs, increased risk of secondary diseases (e.g., mastitis, metritis, ketosis, retained placenta, displaced abomasum), and reduced milk yield and reproductive performance. Subclinical hypocalcemia, defined as blood calcium below 8.0 mg/dL without clinical signs, is even more prevalent and is associated with similar production losses and increased disease risk.

The primary etiological factor is a failure of calcium homeostasis around parturition. The sudden drain of calcium into colostrum (typically 20-30 g of calcium in the first milking) exceeds the rate of calcium influx from bone resorption and intestinal absorption. The underlying causes include: (1) Inadequate dietary calcium intake during the dry period, which suppresses parathyroid hormone (PTH) secretion and reduces the activity of 1-alpha-hydroxylase in the kidney, leading to low levels of 1,25-dihydroxyvitamin D3 (calcitriol). (2) High dietary calcium in the prepartum diet, which further suppresses PTH and calcitriol, making the cow unable to rapidly upregulate calcium transport mechanisms at calving. (3) Dietary magnesium deficiency or excess potassium (which interferes with magnesium absorption), leading to hypomagnesemia, which impairs PTH secretion and end-organ responsiveness. (4) Metabolic alkalosis, often induced by high dietary cation-anion difference (DCAD) in prepartum rations, which reduces the sensitivity of bone and kidney to PTH. (5) Age and parity: older cows (3rd lactation and greater) have reduced bone calcium stores and decreased intestinal calcium absorption efficiency. (6) Breed: Jersey cows are more susceptible due to higher milk production relative to body size and possibly genetic differences in calcium metabolism. (7) Stress, obesity, and poor transition cow management. The disease is not infectious; it is purely metabolic and nutritional in origin.

Parturient paresis occurs worldwide, predominantly in dairy cattle, with a higher incidence in high-producing breeds such as Holstein-Friesian, Jersey, and Brown Swiss. The average incidence in dairy herds is approximately 5-10%, but can reach 25-50% in high-risk herds, especially in older cows (3rd lactation and greater). Beef cattle are less commonly affected, with an incidence of less than 1%, but can occur in high-producing suckler cows. The disease is most common in the first 24-72 hours after calving, with a peak at 12-24 hours. It is rare in heifers (first lactation) due to their lower milk production and more responsive calcium homeostatic mechanisms. Seasonal patterns are not consistent, but there may be an increased risk in spring-calving herds on pasture due to high potassium and low magnesium in lush grass. Herd-level risk factors include high milk production, inadequate dry cow nutrition (especially low magnesium, high potassium, high calcium), and poor transition cow management. Morbidity can be high, and mortality ranges from 1-10% if treated promptly, but can be higher if treatment is delayed or if complications such as downer cow syndrome occur. Economic losses include treatment costs, milk loss (estimated at 100-200 kg per affected cow), increased culling, and increased risk of other periparturient diseases.

The pathophysiology of parturient paresis revolves around acute hypocalcemia and its effects on neuromuscular function. At calving, the sudden demand for calcium for colostrum synthesis (approximately 2.3 g of calcium per kg of colostrum) depletes the extracellular calcium pool. In a normal cow, homeostatic mechanisms involving PTH and calcitriol increase bone resorption and intestinal absorption within 24-48 hours. However, in susceptible cows, these mechanisms are blunted due to prepartum dietary factors (high calcium, high potassium, low magnesium, metabolic alkalosis). The resulting hypocalcemia leads to decreased extracellular calcium concentration, which increases neuronal membrane excitability and impairs neurotransmitter release at the neuromuscular junction. This causes muscle weakness, flaccid paralysis, and decreased smooth muscle contractility. Clinically, this manifests as muscle tremors, ataxia, sternal recumbency, and eventually lateral recumbency and coma. Hypocalcemia also impairs cardiac contractility, leading to bradycardia, weak pulse, and decreased cardiac output. It reduces rumen and gastrointestinal motility, contributing to bloat and constipation. It impairs immune function, increasing susceptibility to infections. Additionally, hypocalcemia can cause a functional deficit in insulin secretion and insulin sensitivity, contributing to hyperglycemia and increased risk of ketosis. The disease is self-limiting if calcium is administered, but without treatment, death occurs due to respiratory failure or cardiac arrest.

Intrinsic factors include: (1) Age and parity: older cows (≥3rd lactation) have reduced bone calcium stores and decreased intestinal calcium absorption efficiency. (2) High milk production: high-yielding cows have a greater calcium demand at calving. (3) Breed: Jerseys are more susceptible than Holsteins. (4) Body condition: overconditioned cows (BCS > 3.5) are at higher risk due to reduced feed intake and increased fat mobilization. (5) Genetics: heritability is low but exists. Extrinsic factors include: (1) Prepartum nutrition: high calcium diets (> 1.5% DM) suppress PTH; high potassium diets (> 1.5% DM) cause metabolic alkalosis and reduce magnesium absorption; low magnesium diets (< 0.4% DM) cause hypomagnesemia. (2) DCAD: positive DCAD (high sodium and potassium) increases risk; negative DCAD (anionic salts) reduces risk. (3) Stress: overcrowding, heat stress, transportation, and other stressors around calving. (4) Management: poor transition cow management, abrupt diet changes, and inadequate calving pen hygiene. (5) Previous history of milk fever: cows that have had milk fever are more likely to recur.

Clinical signs are progressive and can be staged. Stage I (prodromal): occurs 1-2 hours before recumbency; cow is alert but excitable, may show mild ataxia, muscle tremors, especially of the hind legs, and a stiff gait. Body temperature is normal or slightly elevated. Stage II (sternal recumbency): cow is unable to stand but is sternal; she is depressed, anorexic, and has cold extremities. Heart rate is increased (80-100 bpm) with a weak pulse; rumen motility is decreased or absent; pupils are dilated and sluggish; there is a loss of anal reflex and a dry muzzle. Stage III (lateral recumbency): cow is laterally recumbent, comatose, with severe depression. Heart rate is rapid (100-120 bpm) and weak; respiratory rate is depressed; there is bloat due to rumen atony; pupils are unresponsive; the cow may have a subnormal temperature (below 36°C). Without treatment, death occurs within 12-24 hours. In beef cattle, signs may be less severe and more rapid in onset. Subclinical hypocalcemia is common and may present as reduced feed intake, decreased rumen motility, and increased risk of other diseases, but without obvious clinical signs.

Differential diagnoses include: (1) Hypomagnesemia (grass tetany): occurs in lactating cows on pasture, often with low magnesium; signs include hyperesthesia, muscle fasciculations, and convulsions, but calcium levels may be normal or low. (2) Ketosis: occurs in early lactation, but cows are usually alert and have a sweet acetone odor on breath; blood BHB > 1.4 mmol/L. (3) Toxic mastitis (coliform mastitis): cows are febrile, have a swollen udder, and may be recumbent; but they are usually toxic and have a high heart rate, and milk is abnormal. (4) Metritis with toxemia: fever, foul-smelling vaginal discharge, and signs of sepsis. (5) Downer cow syndrome: a cow that is recumbent for > 24 hours after calving, often due to nerve damage or muscle trauma; calcium levels are normal. (6) Abomasal displacement: cows are usually standing but have a ping on the right or left side; they are not recumbent. (7) Periparturient hypophosphatemia: may occur concurrently with hypocalcemia; signs are similar but do not respond to calcium alone. (8) Botulism: flaccid paralysis but occurs in outbreaks and is associated with feed contamination. (9) Spinal cord injury or fracture: sudden recumbency with loss of sensation and motor function in the hind limbs. (10) Acute lead poisoning: neurological signs but usually in calves or cattle exposed to lead.

The diagnostic algorithm for parturient paresis is as follows: (1) Obtain a thorough history: recent calving, stage of lactation, previous episodes, diet, and herd-level incidence. (2) Perform a complete physical examination: assess mentation, temperature, heart rate, respiratory rate, rumen motility, and ability to stand. (3) If the cow is recumbent and in the periparturient period, consider milk fever as a primary differential. (4) Perform a blood test for ionized calcium (or total calcium) to confirm hypocalcemia (ionized Ca < 1.0 mmol/L, total Ca < 5.5 mg/dL). (5) If blood testing is not immediately available, a therapeutic trial of intravenous calcium can be diagnostic: if the cow improves within 30-60 minutes, the diagnosis is confirmed. (6) Rule out other causes of recumbency: check for hypomagnesemia (Mg < 1.8 mg/dL), hyperketonemia (BHB > 1.4 mmol/L), and evidence of infection (fever, abnormal milk, vaginal discharge). (7) If the cow does not respond to calcium therapy, reassess for concurrent conditions such as downer cow syndrome, nerve damage, or other metabolic disorders. (8) In herd outbreaks, evaluate prepartum nutrition, DCAD, and mineral supplementation to identify predisposing factors.

Laboratory findings in parturient paresis include: (1) Blood calcium: total calcium is typically < 5.5 mg/dL (normal 8.5-10.5 mg/dL); ionized calcium is < 1.0 mmol/L (normal 1.1-1.3 mmol/L). (2) Blood phosphorus: often low (< 4.0 mg/dL) due to decreased feed intake and increased renal excretion. (3) Blood magnesium: may be low, normal, or high; low magnesium (< 1.8 mg/dL) is a risk factor and can impair response to calcium therapy. (4) Blood glucose: may be elevated (hyperglycemia) due to stress and decreased insulin secretion. (5) Blood BHB: may be elevated (> 1.4 mmol/L) if concurrent ketosis. (6) Serum NEFA: elevated (> 0.5 mmol/L) due to negative energy balance. (7) Complete blood count: usually within normal limits, but may show hemoconcentration (elevated PCV) due to dehydration. (8) Rumen fluid analysis: pH may be normal or slightly alkaline due to decreased fermentation; protozoal motility is reduced. (9) Urinalysis: may show ketonuria if concurrent ketosis. (10) Electrocardiogram: may show bradycardia, prolonged QT interval, and ST segment changes due to hypocalcemia.

Imaging is not typically used for the diagnosis of parturient paresis, but may be employed to rule out other conditions. Ultrasonography of the abdomen can be used to assess rumen motility, abomasal position, and the presence of free fluid. In recumbent cows, ultrasonography of the hind limbs can help identify muscle damage or nerve injury. Radiography is rarely used but may be helpful to rule out pelvic fractures or spinal lesions. In cases of suspected concurrent disease, thoracic ultrasonography can detect pneumonia or pleural effusion. However, imaging is not essential for diagnosis and is often not feasible in field conditions.

Cytology and histopathology are not commonly performed for parturient paresis, as the diagnosis is based on clinical signs and blood calcium levels. However, if a cow dies or is euthanized, necropsy may reveal no specific gross lesions. Histologically, there may be evidence of muscle degeneration (rhabdomyolysis) due to prolonged recumbency, and possibly renal calcification. In cases of concurrent disease, histopathology of the udder, uterus, or lungs may reveal mastitis, metritis, or pneumonia. Peritoneal fluid analysis may be performed if peritonitis is suspected, but is not part of the routine workup.

Treatment of parturient paresis is an emergency and involves the rapid correction of hypocalcemia. The primary treatment is the slow intravenous administration of calcium borogluconate. The standard dose is 500 mL of a 23% calcium borogluconate solution (equivalent to 11.5 g of calcium) given IV over 10-20 minutes. This is often combined with magnesium and phosphorus (e.g., 500 mL of a solution containing calcium, magnesium, and phosphorus). The cow should be monitored for cardiac arrhythmias during IV administration; if the heart rate becomes irregular or the cow shows signs of distress, the infusion should be stopped temporarily. After IV therapy, oral calcium supplementation (e.g., calcium boluses or drench) may be given to maintain calcium levels. In addition, supportive care includes: (1) Rolling the cow to the opposite side after 6-8 hours if she is in lateral recumbency to prevent muscle damage and bloat. (2) Providing a comfortable, well-bedded area to prevent pressure sores. (3) Administering fluids if dehydrated, but avoid overhydration. (4) Treating concurrent conditions such as hypomagnesemia (e.g., 200-300 mL of 50% magnesium sulfate SC) or ketosis (e.g., propylene glycol orally). (5) Using anti-inflammatory drugs (e.g., flunixin meglumine 1.1-2.2 mg/kg IV) if there is muscle trauma. (6) In severe cases, a second IV calcium infusion may be needed after 6-12 hours. (7) If the cow does not respond to calcium therapy, reassess for other causes of recumbency. (8) For downer cows, physical therapy and slings may be used, but prognosis is guarded.

The prognosis for parturient paresis is good if treated promptly and if no complications arise. Most cows (80-90%) respond to a single IV calcium infusion and are standing within 30-60 minutes. However, the prognosis worsens if treatment is delayed, if the cow is in lateral recumbency for more than 6-8 hours, or if concurrent diseases are present. Complications such as downer cow syndrome, muscle necrosis, nerve damage, and secondary infections can lead to a poor prognosis. Cows that do not respond to two calcium infusions have a guarded prognosis. The long-term prognosis for milk production and fertility is generally good for cows that recover, but they are at increased risk for other periparturient diseases and may have reduced milk yield in the current lactation. The risk of recurrence in subsequent lactations is high.

Follow-up care for a cow treated for parturient paresis includes: (1) Monitor the cow closely for 24-48 hours for recurrence of signs. (2) Provide oral calcium supplementation (e.g., calcium boluses) for 2-3 days after the initial treatment. (3) Ensure the cow has access to fresh water and high-quality feed. (4) Monitor for complications such as mastitis, metritis, ketosis, and displaced abomasum. (5) Check blood calcium and magnesium levels if the cow does not improve. (6) In the herd, review prepartum nutrition and management to prevent future cases. (7) Implement a transition cow program with appropriate DCAD, magnesium supplementation, and calcium restriction prepartum. (8) Consider using oral calcium boluses at calving for high-risk cows (e.g., older cows, Jerseys). (9) Monitor the herd for subclinical hypocalcemia by testing blood calcium in a sample of fresh cows.

Clinical pearls: (1) Always consider milk fever in any recumbent cow within 72 hours of calving. (2) A therapeutic trial of IV calcium is both diagnostic and therapeutic. (3) Administer IV calcium slowly and monitor heart rate; if bradycardia or arrhythmia occurs, stop and restart at a slower rate. (4) Combine calcium with magnesium and phosphorus if available. (5) After IV calcium, give oral calcium to prevent relapse. (6) Roll a laterally recumbent cow every 6 hours to prevent muscle damage. (7) Use a sling or hip lift to help a cow stand if she is down but alert. (8) In herd outbreaks, evaluate the DCAD of the prepartum diet. Pitfalls: (1) Do not give IV calcium too rapidly, as it can cause cardiac arrest. (2) Do not give calcium subcutaneously in a recumbent cow, as it can cause tissue necrosis. (3) Do not assume that a cow that does not respond to calcium has milk fever; consider other causes of recumbency. (4) Do not neglect to check for hypomagnesemia, as it can cause a poor response to calcium. (5) Do not forget to treat concurrent conditions such as ketosis or mastitis. (6) Do not use oral calcium as the sole treatment for severe hypocalcemia, as it is not absorbed quickly enough. (7) Do not overinflate the rumen with oral fluids in a recumbent cow, as it can cause aspiration.

Current drug protocols for parturient paresis are based on Plumb's Veterinary Drug Handbook and AABP guidelines. (1) Calcium borogluconate 23% solution: IV, 500 mL (11.5 g calcium) per cow, slow infusion over 10-20 minutes. May repeat in 6-12 hours if needed. Withdrawal: zero for milk and meat if used as labeled. (2) Calcium borogluconate with magnesium and phosphorus (e.g., 500 mL containing 10 g calcium, 5 g magnesium, 3 g phosphorus): IV, 500 mL per cow, slow infusion. (3) Magnesium sulfate 50% solution: SC, 200-300 mL per cow (100-150 g magnesium) for concurrent hypomagnesemia. (4) Oral calcium bolus (e.g., 50-100 g calcium as calcium chloride or calcium propionate): PO, 1-2 boluses at calving and again in 12-24 hours for prevention or after IV therapy. (5) Propylene glycol: PO, 250-300 mL per cow, q24h for 3-5 days if concurrent ketosis. (6) Flunixin meglumine: IV, 1.1-2.2 mg/kg, q24h for 1-3 days for anti-inflammatory and analgesic effects. (7) Dexamethasone: IV or IM, 20-40 mg per cow, once, may be used in severe cases to reduce inflammation, but is not routinely recommended. (8) Ceftiofur hydrochloride: SC, 2.2 mg/kg, q24h for 3-5 days if secondary bacterial infection is suspected. (9) Oxytetracycline: IV, 10-20 mg/kg, q24h for 3-5 days, but use with caution in recumbent cows. (10) Intra-mammary antibiotics (e.g., ceftiofur, amoxicillin) for mastitis treatment, but only if mastitis is present. All drugs must be used according to label and with appropriate withdrawal times.

Landmark studies and consensus guidelines: (1) The classic study by Jorgensen (1974) demonstrated that feeding low calcium diets prepartum reduces the incidence of milk fever. (2) The concept of DCAD was introduced by Block (1984) and later refined by Goff and Horst (1997), showing that negative DCAD diets reduce milk fever risk. (3) A meta-analysis by Lean et al. (2006) confirmed that prepartum dietary calcium restriction and negative DCAD are effective preventive measures. (4) The use of oral calcium boluses at calving has been shown to reduce the incidence of clinical and subclinical hypocalcemia (Oetzel, 2013). (5) The AABP (American Association of Bovine Practitioners) has published guidelines on transition cow management and milk fever prevention. (6) The ECBHM (European College of Bovine Health Management) includes milk fever in its core curriculum. (7) Recent studies have focused on the role of subclinical hypocalcemia in increasing the risk of other diseases, such as metritis and displaced abomasum (Chapinal et al., 2012). (8) Research on genetic selection for resistance to milk fever is ongoing. (9) The use of vitamin D analogs (e.g., calcitriol) prepartum has been studied but is not widely adopted due to cost and timing issues. (10) Overall, the evidence strongly supports the importance of transition cow nutrition and management in preventing milk fever.